|
1
|
Prince M, Wimo A, Guerchet M, Ali GC, Wu
YT and Prina M: An analysis of prevalence, incidence, cost and
trends. World Alzheimer Report 2015. The Global Impact of Dementia.
Alzheimer's Disease International (ADI). (London). 2015.https://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf
|
|
2
|
Li XY, Bao XJ and Wang RZ: Potential of
neural stem cell-based therapies for Alzheimer's disease. J
Neurosci Res. 93:1313–1324. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Beason-Held LL, Goh JO, An Y, Kraut MA,
O'Brien RJ, Ferrucci L and Resnick SM: Changes in brain function
occur years before the onset of cognitive impairment. J Neurosci.
33:18008–18014. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chao LL, Buckley ST, Kornak J, Schuff N,
Madison C, Yaffe K, Miller BL, Kramer JH and Weiner MW: ASL
perfusion MRI predicts cognitive decline and conversion from MCI to
dementia. Alzheimer Dis Assoc Disord. 24:19–27. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim SM, Kim MJ, Rhee HY, Ryu CW, Kim EJ,
Petersen ET and Jahng GH: Regional cerebral perfusion in patients
with Alzheimer's disease and mild cognitive impairment: Effect of
APOE Epsilon4 allele. Neuroradiology. 55:25–34. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nicolakakis N and Hamel E: Neurovascular
function in Alzheimer's disease patients and experimental models. J
Cereb Blood Flow Metab. 31:1354–1370. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bell RD and Zlokovic BV: Neurovascular
mechanisms and blood-brain barrier disorder in Alzheimer's disease.
Acta Neuropathol. 118:103–113. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zlokovic BV: Role of the brain vascular
system and blood-brain barrier transport in clearance of
alzheimer's amyloid-beta peptide from the central nervous system.
US Patent 20,050,239,062, Filed. May 23–2001.issued October 27
2005.
|
|
9
|
Inoue Y, Tanaka Y, Hata H and Hara T:
Arterial spin-labeling evaluation of cerebrovascular reactivity to
acetazolamide in healthy subjects. AJNR Am J Neuroradiol.
35:1111–1116. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Verclytte S, Lopes R, Lenfant P, Rollin A,
Semah F, Leclerc X, Pasquier F and Delmaire C: Cerebral
hypoperfusion and hypometabolism detected by arterial spin labeling
MRI and FDG-PET in early-onset Alzheimer's disease. J Neuroimaging.
26:207–212. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maier FC, Wehrl HF, Schmid AM, Mannheim
JG, Wiehr S, Lerdkrai C, Calaminus C, Stahlschmidt A, Ye L, Burnet
M, et al: Longitudinal PET-MRI reveals β-amyloid deposition and
rCBF dynamics and connects vascular amyloidosis to quantitative
loss of perfusion. Nat Med. 20:1485–1492. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Z: Characterizing early Alzheimer's
disease and disease progression using hippocampal volume and
arterial spin labeling perfusion MRI. J Alzheimers Dis. 42 (Suppl
4):S495–S502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kerbler GM, Fripp J, Rowe CC, Villemagne
VL, Salvado O, Rose S and Coulson EJ; Alzheimer's Disease
Neuroimaging Initiative, : Basal forebrain atrophy correlates with
amyloid β burden in Alzheimer's disease. Neuroimage Clin.
7:105–113. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Badea A, Johnson GA and Jankowsky JL:
Remote sites of structural atrophy predict later amyloid formation
in a mouse model of Alzheimer's disease. Neuroimage. 50:416–427.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Burns JM, Donnelly JE, Anderson HS, Mayo
MS, Spencer-Gardner L, Thomas G, Cronk BB, Haddad Z, Klima D,
Hansen D and Brooks WM: Peripheral insulin and brain structure in
early Alzheimer disease. Neurology. 69:1094–1104. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li XY, Men WW, Zhu H, Lei JF, Zuo FX, Wang
ZJ, Zhu ZH, Bao XJ and Wang RZ: Age- and brain region-specific
changes of glucose metabolic disorder, learning, and memory
dysfunction in early Alzheimer's disease assessed in APP/PS1
transgenic mice using 18F-FDG-PET. Int J Mol Sci.
17:E17072016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang H, Liu J, Zong Y, Xu Y, Deng W, Zhu
H, Liu Y, Ma C, Huang L, Zhang L and Qin C: miR-106b aberrantly
expressed in a double transgenic mouse model for Alzheimer's
disease targets TGF-β type II receptor. Brain Res. 1357:166–174.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zong YY, Wang XY, Wang HL, Liu YL, Huang
L, Ma CM, Zhang LF and Qin C: Continuous analysis of senile plaque
and behaviour in APPswe/PSΔE9 double-transgenic gene mouse model of
Alzheimer disease. Chin J Comp Med. 2008.http://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGDX200809003.htm
|
|
19
|
Li X, Zhu H, Sun X, Zuo F, Lei J, Wang Z,
Bao X and Wang R: Human neural stem cell transplantation rescues
cognitive defects in APP/PS1 model of Alzheimer's disease by
enhancing neuronal connectivity and metabolic activity. Front Aging
Neurosci. 8:2822016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nasrallah FA, Lee EL and Chuang KH:
Optimization of flow-sensitive alternating inversion recovery
(FAIR) for perfusion functional MRI of rodent brain. NMR Biomed.
25:1209–1216. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bitner BR, Brink DC, Mathew LC, Pautler RG
and Robertson CS: Impact of arginase II on CBF in experimental
cortical impact injury in mice using MRI. J Cereb Blood Flow Metab.
30:1105–1109. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Paxinos G and Franklin KBJ: The Mouse
Brain in Stereotaxic Coordinates. Second edition. Academic Press.
(San Diego). 2001.
|
|
23
|
Zhang L, Liu C, Wu J, Tao JJ, Sui XL, Yao
ZG, Xu YF, Huang L, Zhu H, Sheng SL and Qin C: Tubastatin
A/ACY-1215 improves cognition in Alzheimer's disease transgenic
mice. J Alzheimers Dis. 41:1193–1205. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hampel H, Prvulovic D, Teipel S, Jessen F,
Luckhaus C, Frölich L, Riepe MW, Dodel R, Leyhe T, Bertram L, et
al: The future of Alzheimer's disease: The next 10 years. Prog
Neurobiol. 95:718–728. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li X, Bao X and Wang R: Experimental
models of Alzheimer's disease for deciphering the pathogenesis and
therapeutic screening (Review). Int J Mol Med. 37:271–283. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Abrahamson EE, Foley LM, Dekosky ST,
Hitchens TK, Ho C, Kochanek PM and Ikonomovic MD: Cerebral blood
flow changes after brain injury in human amyloid-beta knock-in
mice. J Cereb Blood Flow Metab. 33:826–833. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hébert F, Grand'maison M, Ho MK, Lerch JP,
Hamel E and Bedell BJ: Cortical atrophy and hypoperfusion in a
transgenic mouse model of Alzheimer's disease. Neurobiol Aging.
34:1644–1652. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dickstein DL, Walsh J, Brautigam H,
Stockton SD Jr, Gandy S and Hof PR: Role of vascular risk factors
and vascular dysfunction in Alzheimer's disease. Mt Sinai J Med.
77:82–102. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Beach TG, Wilson JR, Sue LI, Newell A,
Poston M, Cisneros R, Pandya Y, Esh C, Connor DJ, Sabbagh M, et al:
Circle of Willis atherosclerosis: Association with Alzheimer's
disease, neuritic plaques and neurofibrillary tangles. Acta
Neuropathol. 113:13–21. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mattsson N, Tosun D, Insel PS, Simonson A,
Jack CR Jr, Beckett LA, Donohue M, Jagust W, Schuff N and Weiner
MW; Alzheimer's Disease Neuroimaging Initiative, : Association of
brain amyloid-β with cerebral perfusion and structure in
Alzheimer's disease and mild cognitive impairment. Brain.
137:1550–1561. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Platt B, Welch A and Riedel G: FDG-PET
imaging, EEG and sleep phenotypes as translational biomarkers for
research in Alzheimer's disease. Biochem Soc Trans. 39:874–880.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jupp B, Williams J, Binns D, Hicks RJ,
Cardamone L, Jones N, Rees S and O'Brien TJ: Hypometabolism
precedes limbic atrophy and spontaneous recurrent seizures in a rat
model of TLE. Epilepsia. 53:1233–1244. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Michels L, Warnock G, Buck A, Macauda G,
Leh SE, Kaelin AM, Riese F, Meyer R, O'Gorman R, Hock C, et al:
Arterial spin labeling imaging reveals widespread and
Aβ-independent reductions in cerebral blood flow in elderly
apolipoprotein epsilon-4 carriers. J Cereb Blood Flow Metab.
36:581–595. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wierenga CE, Hays CC and Zlatar ZZ:
Cerebral blood flow measured by arterial spin labeling MRI as a
preclinical marker of Alzheimer's disease. J Alzheimers Dis. 42
(Suppl 4):S411–S419. 2014. View Article : Google Scholar : PubMed/NCBI
|
